A detailed history of Eqis Capital Management, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 5,699 shares of ZTS stock, worth $930,760. This represents 0.09% of its overall portfolio holdings.

Number of Shares
5,699
Previous 4,067 40.13%
Holding current value
$930,760
Previous $705,000 57.87%
% of portfolio
0.09%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$172.58 - $196.48 $281,650 - $320,655
1,632 Added 40.13%
5,699 $1.11 Million
Q2 2024

Aug 13, 2024

BUY
$145.54 - $178.83 $76,845 - $94,422
528 Added 14.92%
4,067 $705,000
Q1 2024

May 14, 2024

BUY
$165.67 - $199.94 $194,330 - $234,529
1,173 Added 49.58%
3,539 $598,000
Q4 2023

Feb 14, 2024

SELL
$151.44 - $200.09 $59,061 - $78,035
-390 Reduced 14.15%
2,366 $466,000
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $152,598 - $175,999
913 Added 49.54%
2,756 $479,000
Q2 2023

Aug 14, 2023

BUY
$160.94 - $186.23 $296,612 - $343,221
1,843 New
1,843 $317,000
Q3 2022

Oct 24, 2022

SELL
$148.29 - $182.55 $26,840 - $33,041
-181 Reduced 11.62%
1,377 $204,000
Q2 2022

Aug 08, 2022

BUY
$155.97 - $200.09 $243,001 - $311,740
1,558 New
1,558 $267,000
Q1 2022

May 16, 2022

SELL
$181.39 - $234.03 $184,292 - $237,774
-1,016 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$193.69 - $247.03 $30,603 - $39,030
-158 Reduced 13.46%
1,016 $248,000
Q3 2021

Nov 12, 2021

BUY
$189.29 - $209.69 $222,226 - $246,176
1,174 New
1,174 $228,000
Q1 2018

Apr 06, 2018

SELL
$71.51 - $84.69 $391,874 - $464,101
-5,480 Closed
0 $0
Q4 2017

Jan 25, 2018

BUY
$63.24 - $72.8 $346,555 - $398,944
5,480
5,480 $395,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $76.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Eqis Capital Management, Inc. Portfolio

Follow Eqis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.